fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » UTI Healthcare Fund

UTI Healthcare Fund - G

NAV  ₹227.129 ↑ 0.60  (0.26 %) as on 22 Feb 24

(Erstwhile UTI Pharma & Healthcare Fund)

Scheme Objective

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund launched on 28 Jun 99. It is a fund with High risk and has given a CAGR return of 14.8% since its launch.  Ranked 40 in Sectoral category.  Return for 2023 was 38.2% , 2022 was -12.3% and 2021 was 19.1% .

Below is the key information for UTI Healthcare Fund

NAV as on 22 Feb 24₹227.129 ↑ 0.60  (0.26 %)
Net Assets (AUM) as on 31 Jan 2024 ₹919 Cr.
Launch Date28 Jun 1999
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCUTI Asset Management Company Ltd
Alpha Ratio1.59
Expense Ratio2.47 %
Sharpe Ratio2.26
Information Ratio-0.55
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 22 Feb 24

DurationReturns
1 Month 7.4%
3 Month 15.9%
6 Month 23.7%
1 Year 57.5%
3 Year 18.6%
5 Year 22.6%
10 Year
15 Year
Since launch 14.8%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2023 38.2%
2022 -12.3%
2021 19.1%
2020 67.4%
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%

Growth of 10k Over Years

DateValue
31 Jan 19₹10,000
31 Jan 20₹10,464
31 Jan 21₹16,171
31 Jan 22₹18,756
31 Jan 23₹17,297
31 Jan 24₹25,759
UTI Healthcare Fund Growth 10k Chart

Asset Allocation

Asset ClassValue
Cash1.5%
Equity98.5%
UTI Healthcare Fund Asset Allocation

Sector Allocation

SectorValue
Health Care96.46%
Basic Materials1.42%
Financial Services0.61%
UTI Healthcare Fund Equity Allocation

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
Drug Manufacturers - Specialty & Generic13%₹111 Cr880,000
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA
Drug Manufacturers - General7%₹62 Cr500,000
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP
Medical Care Facilities7%₹61 Cr107,587
↓ -413
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
Drug Manufacturers - Specialty & Generic7%₹57 Cr98,643
Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM
Drug Manufacturers - Specialty & Generic5%₹45 Cr214,336
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
Drug Manufacturers - Specialty & Generic5%₹41 Cr380,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS
Medical Care Facilities5%₹40 Cr950,000
↓ -65,000
Suven Pharmaceuticals Ltd (Healthcare)
Equity, Since 28 Feb 21 | SUVENPHAR
Drug Manufacturers - Specialty & Generic4%₹32 Cr440,000
↓ -25,000
Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Jun 21 | 543308
Medical Care Facilities4%₹31 Cr158,483
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
Drug Manufacturers - Specialty & Generic3%₹28 Cr70,943
↓ -5,057
1 - 10 of 39
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Kamal Gada2 May 221.75 Yr.

Custodians

CompanyAddress
Bank of Nova Scotia12/13, Maker Chamber VI,220, Nariman Point
Citibank N.A. IndiaTrent House, 3rd Floor, G Block,,Plot No.60, Next to Citibank,,Bandra Kurla Complex,,Bandra (East),
Stock Holding Corporation of IndiaMittal Court, ‘B’ Wing,,Nariman Point

Registrar & Transfer Agent

KFin Technologies Ltd
AddressKFin Technologies Pvt. Ltd,,1D/D Extension 2, Valmiki Chowk,,Gandhi Nagar,
FAX91-40-23311968
Emailmailmanager@karvy.com

Administrator Companies

CompanyAddress
UTI Mutual FundUTI Tower , `GN' Block,,Bandra Kurla Complex,,Bandra (E)

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
UTI Healthcare Fund
Growth
₹227.129
↑ 0.60
23.73 %57.51 %18.65 %22.6 %
UTI Healthcare Fund
Normal Dividend, Payout
₹175.539
↑ 0.46
23.73 %57.51 %18.65 %22.6 %
UTI Healthcare Fund
Normal Dividend, Reinvestment
₹175.539
↑ 0.46
23.73 %57.51 %18.65 %22.6 %
Data as on 22 Feb 24

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.